Beowulf Asset Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BEOWULF ASSET, and what generic and branded alternatives to BEOWULF ASSET drugs are available?
BEOWULF ASSET has one approved drug.
Drugs and US Patents for Beowulf Asset
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beowulf Asset | NYSTATIN | nystatin | POWDER;TOPICAL | 065175-001 | Dec 17, 2004 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.